Subscribe To
Ticking time bombs: 3 meme stocks to dump before the damage is done
Meme stocks are typically low-priced stocks with a high social media interest. Another factor that's co...
October 1, 2023, 2:00 pm
You don't have to pick a winner in clean energy
The world is shifting toward lower-carbon energy sources, which will likely require decades of investment. If you are looking at clean energy, how do ...
October 1, 2023, 11:00 am
Amazon's makes 'strategic move' to invest up to $4 billion in anthropic generative ai
Amazon (AMZN) has made an investment in the AI firm Anthropic, announcing their willingness to commit u...
October 1, 2023, 10:00 am
9% return yield at $90 oil - diamondback is the only fang you need
Oil prices are rising due to supply constraints and strong export demand, despite weak economic growth. Diamondback Energy is a top ...
October 1, 2023, 9:00 am
3 no-brainer growth stocks to buy in october
October has typically been a solid month for stocks. CRISPR Therapeutics, DraftKings, and Roivant Scien...
October 1, 2023, 8:30 am
Big food vs. big pharma: companies bet on snacking just as weight loss drugs boom
Kellogg, J.M. Smucker and other food companies are making big bets on snacking, but the rise of Wegovy and Ozem...
October 1, 2023, 8:00 am
Top wall street analysts pick these five stocks for compelling returns
TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Adobe & Salesforce...
October 1, 2023, 7:53 am
A bull market could be here: 3 reasons to buy uber stock
Uber's most typical customer is not only unlikely to purchase a car in the future, but will require mor...
October 1, 2023, 7:20 am
Here's the michael burry stock that could be the biggest winner over the next 5 years
Michael Burry is best known for his short positions but is long on nearly 30 stocks. One of his contrarian pic...
October 1, 2023, 5:50 am
Ticking time bombs: 3 nasdaq stocks to dump before the damage is done
Although an inherently uncomfortable topic, investors need to seriously consider the idea of certain Na...
September 30, 2023, 4:19 pm
Why nio stock could double over the next 12 months
Nio (NYSE: NIO ) stands as a prominent pick in China's electric vehicle market. However, NIO stock has ...
September 30, 2023, 12:18 pm
Mattel releasing ai version of pictionary
This segment originally aired on September 27, 2023. Mattel (MAT) will be releasing a new AI version of its game ...
September 30, 2023, 7:00 am
Nissan: earnings are picking up
Renault and Nissan have entered a new phase in their decade-long relationship, with the Japanese carmaker investing approximately €600 million in Am...
September 30, 2023, 6:27 am
Thermo fisher: i'm waiting for a better valuation in this high-quality business
Thermo Fisher Scientific provides laboratory instruments, reagents, and consumables for scientific research and healthcare applications. These are the...
September 30, 2023, 4:02 am
Eur/aud weekly outlook
EUR/AUD’s fall from 1.7062 resumed last week and hit as low as 1.6319. Outlook is unchanged that this decline is seen as a larger scale correction. ...
September 30, 2023, 3:48 am
Qabil pays a heavy price for his historic gold
QABIL Ambak has won a historic Asian Games gold medal in equestrian but it also comes with a big price. Qabil revealed that he has given up on his hop...
September 29, 2023, 11:44 pm
Ticking time bombs: 3 value stocks to dump before the damage is done
Value stocks can have a lot of benefits for investors. Typically, they are larger, well-established com...
September 29, 2023, 11:15 pm
Usdjpy: what technical levels are in play for the week starting october 2, 2023.
The USDJPY had a volatile down and up trading day with the full 100 pip move to the downside in the first half of the day, nearly fully retracted in t...
September 29, 2023, 6:52 pm
Regulators approve bill ackman's special purpose acquisition rights company
CNBC's Leslie picker and Mike Santoli report on breaking news concerning billionaire investor Bill Ackm...
September 29, 2023, 5:47 pm
Goldman sachs' chris shibutani talks his top biotech picks including eli lilly and pfizer
Chris Shibutani, Goldman Sachs Senior Analyst, joins 'Closing Bell Overtime' to talk his top picks in t...
September 29, 2023, 5:43 pm